Toll Free: 1-888-638-4847
Law Offices of Howard G. Smith
3070 Bristol Pike, Suite 112
Bensalem, PA 19020
Telephone: (215) 638-4847
Facsimile: (215) 638-4867
Speak to a Lawyer, Not a Receptionist!
ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD)
Copyright © 2006-2018 Law Offices of Howard G. Smith
This lawsuit is for anyone who acquired securities in ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD) from April 29, 2016 through July 9, 2018.

The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, the lawsuit alleges that, during the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company misled the FDA to get the FDA to approve Nuplazid, the Company's drug for treating psychosis in people with Parkinson’s disease. The Law Offices of Howard G. Smith also believes that the Company then bribed doctors to prescribe the drug despite knowing of the drug's safety and efficacy issues. The Company failed to disclose any of the problems with the drug, or the Company's questionable marketing and approval practices to the investing public, despite knowing that when the public discovered that the drug was unsafe the discovery would have a negative financial impact on the Company.

On April 9, 2018, CNN reported that “[p]hysicians, medical researchers and other experts told CNN that they worried that [Nuplazid] had been approved too quickly, based on too little evidence that it was safe or effective.” On this news, the price of the Company's stock dropped precipitously on unusually heavy trading volume. Then, on April 25, 2018, CNN reported that the U.S. Food and Drug Administration was re-examining the safety of Nuplazid. On this news, the price of the Company's stock again dropped precipitously on unusually heavy trading volume. Finally, on July 9, 2018, The Southern Investigative Reporting Foundation published a report alleging that ACADIA’s “pursuit of regulatory approval is best described as ‘loophole-centric’.” On this news, the price of the Company's stock again dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD) from April 29, 2016 through July 9, 2018, you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.
Case Summary
Join the Class Action
First Name: *
Last Name: *
Middle Initial:
If Representing an Institution, Name of Institution:
If Representing an Institution, Position at Institution:
Mailing Address: *
City: *
State: *
Zip Code:
Country: *
Facsimile #:
Phone #: *
Email *
I, the Plaintiff, certify that:
1.  I have reviewed the Complaint and authorized its filing.

2.  Plaintiff did not purchase the security that is the subject of this
     action, at the direction of plaintiff's counsel or in order to   
     participate in any private action arising under this title.

3.  I am willing to serve as a representative party on behalf of a class
     and will testify at deposition and trial, if necessary.

4.  My transactions in the securities, which are the subject of this 
     action, during the Class Period set forth in the Complaint are as
     follows:
Enter share information:
Read the Complaint
See Press Release
Shares Purchased:
Type of Security:
# of Shares:*
Buy Date:*
Price per Share:*
Shares Sold:
Type of Security:
Sell Date:
# of shares:
Price per share:
5.  I have not served as a representative party on behalf of a class
     under the federal security laws during the last three years, except
     if detailed below.
6.  I will not accept any payment for serving as a representative party,
     except to receive my pro rata share of any recovery or as ordered
     or approved by the court including the award to a representative
     plaintiff of reasonable costs and expenses (including lost wages)
     directly relating to the representation of the class.
Terms:
correct statements.
agreement and retain the Law Offices of Howard G. Smith and its associates to proceed on Plaintiff's behalf, on a contingent fee basis.  If I am executing this agreement on behalf of an institution, I further certify that I am authorized to execute this agreement on behalf of the institution.
*Are you now or were you ever an employee of the
  company?
* I declare under penalty of perjury that the foregoing are true and
* By clicking on the button below, I intend to sign and execute this 
YesNo